Brain tumor CT: Difference between revisions
Jump to navigation
Jump to search
(→CT) |
No edit summary |
||
Line 14: | Line 14: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Disease]] | [[Category:Disease]] |
Revision as of 14:58, 20 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Brain tumor Microchapters |
Overview
Imaging plays a central role in the diagnosis of brain tumors. Early imaging methods—invasive and sometimes dangerous—such as pneumoencephalography and cerebral angiography, have been abandoned in recent times in favor of non-invasive, high-resolution modalities, such as computed tomography (CT) and especially magnetic resonance imaging (MRI).
CT
- Benign brain tumors often show up as hypodense (darker than brain tissue) mass lesions on cranial CT-scans. Contrast agent uptake, sometimes in characteristic patterns, can be demonstrated on either CT or MRI-scans in most malignant primary and metastatic brain tumors. This is due to the fact that these tumors disrupt the normal functioning of the blood-brain barrier and lead to an increase in its permeability.
- Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) have complementary roles in the diagnosis of CNS neoplasms.[1] [2]The speed of CT is desirable for evaluating clinically unstable patients. CT is superior for detecting calcification, skull lesions, and hyperacute hemorrhage (bleeding less than 24-hours old) and helps direct differential diagnosis as well as immediate management.